КФУ. Карточка публикации. ?Assessment of Russian clinical practice guidelines with the AGREE II instrument?

КАЗАНСКИЙ
ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ

RUS

- EN
- 中文
- ES

?ASSESSMENT OF RUSSIAN CLINICAL PRACTICE GUIDELINES WITH THE AGREE II INSTRUMENT?

Форма представления

Тезисы и материалы конференций в зарубежных журналах и сборниках

Год публикации

2017

Авторы, сотрудники КФУ

Зиганшина Лилия Евгеньевна, автор

Авторы, аспиранты КФУ

Кисарь Лидия Вячеславовна, автор

Библиографическое описание на языке оригинала

Kisser LV., Ziganshina LE.

Аннотация

Clinical practice guidelines (CPGs) became increasingly important in the Russian health environment as support tools for clinical decision making and interaction with health insurers. Over the last decades, a series of countrywide, guideline-like documents were developed and used mainly in health financing. However, not all health professionals are clear what guidelines are for, how they should be developed and used. Promotion of health technologies by manufacturers is a widespread and accepted reality, while the process/methodology of guideline development and assessment seem to be not fully established.

Ключевые слова

Clinical practice guidelines,AGREE II,clinical pharmacology, methodological quality

Место издания

Cape Town, South Africa

Издательство

Cochrane Database of Systematic Reviews

URL

10.1002/14651858.CD201702

Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на эту карточку

https://repository.kpfu.ru/?p_id=159659

Полная запись метаданных

Поле DC	Значение	Язык
dc.contributor.author	Зиганшина Лилия Евгеньевна	ru_RU
dc.contributor.author	Кисарь Лидия Вячеславовна	ru_RU
dc.date.accessioned	2017-01-01T00:00:00Z	ru_RU
dc.date.available	2017-01-01T00:00:00Z	ru_RU
dc.date.issued	2017	ru_RU
dc.identifier.citation	Kisser LV., Ziganshina LE.	ru_RU
dc.identifier.uri	https://repository.kpfu.ru/?p_id=159659	ru_RU
dc.description.abstract	Clinical practice guidelines (CPGs) became increasingly important in the Russian health environment as support tools for clinical decision making and interaction with health insurers. Over the last decades, a series of countrywide, guideline-like documents were developed and used mainly in health financing. However, not all health professionals are clear what guidelines are for, how they should be developed and used. Promotion of health technologies by manufacturers is a widespread and accepted reality, while the process/methodology of guideline development and assessment seem to be not fully established.	ru_RU
dc.language.iso	ru	ru_RU
dc.publisher	Cochrane Database of Systematic Reviews	ru_RU
dc.subject	Clinical practice guidelines	ru_RU
dc.subject	AGREE II	ru_RU
dc.subject	clinical pharmacology	ru_RU
dc.subject	methodological quality	ru_RU
dc.title	?Assessment of Russian clinical practice guidelines with the AGREE II instrument?	ru_RU
dc.type	Тезисы и материалы конференций в зарубежных журналах и сборниках	ru_RU